http://linkedlifedata.com/r... | rdf:type | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | UK | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | Bioorg.Med.Chem. | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | BMECEP | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | 1200 | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | 0968-0896 | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | 12 | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | 907 | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | 920 | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | 10.1016/j.bmc.2003.12.019 | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:114980603 | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | 3,5-Substituted phenyl galactosides as leads in designing effective cholera toxin antagonists; synthesis and crystallographic studies | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | lld:pdb |